1 |
Isolation and characterisation of novel lytic bacteriophages for therapeutic applications in biofilm-associated prosthetic joint infections |
2 |
Understanding the genome architecture and evolution of Shiga toxin encoding bacteriophages of Escherichia coli |
3 |
Alternatives to overcoming bacterial resistances: state-of-the-art |
4 |
The phage therapy paradigm: prêt-à-porter or sur-mesure? |